info icon

This is a non-core endpoint: only basic statistics are computed.

Benign neoplasm: Renal pelvis

CD2_BENIGN_RENALPELVIS

kidney neoplasm: A benign or malignant neoplasm affecting the kidney. Representative examples of benign renal neoplasms include fibroma, lipoma, oncocytoma, and juxtaglomerular cell tumor. Representative examples of malignant renal neoplasms include renal cell carcinoma, renal pelvis carcinoma, Wilms tumor, rhabdoid tumor, sarcoma, and lymphoma.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D30.1&
Hospital discharge: ICD-9 2231
Hospital discharge: ICD-8 2231
Cause of death: ICD-10 D30.1&
Cause of death: ICD-9 2231
Cause of death: ICD-8 2231

2 out of 7 registries used, show all original rules.

45

diagram downward connector

Check minimum number of events None

45

diagram downward connector

Include endpoints None

45

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

45

diagram downward connector
CD2_BENIGN_RENALPELVIS

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D30
Name in latin Neoplasma benignum pelvis renalis

Summary Statistics

Key figures

All Female Male
Number of individuals 45 27 18
Unadjusted prevalence (%) 0.01 0.01 0.01
Mean age at first event (years) 60.53 52.79 72.14

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: CD2_BENIGN_RENALPELVIS – Benign neoplasm: Renal pelvis
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Benign neoplasm: Renal pelvis

Endpoint not on priority list, no data to show.